October 1, 2015
The Japan Pharmaceutical Wholesalers Association (JPWA) on September 30 called on drug makers to fairly share costs associated with the distribution of products eligible for the so-called innovation premium designed to maintain the prices of on-patent medicines. JPWA President Ken...read more